Hydreight Technologies Inc. (TSXV:NURS)

Revenue by Product

Financial numbers in millions CAD.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
Pharmacy	7.7
Pharmacy Growth	191.14%
Business Partner Contract	3.22
Business Partner Contract Growth	142.66%
Commission	0.58
Commission Growth	98.18%

Revenue by Geography

Financial numbers in millions CAD.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
Canada	11.51
Canada Growth	169.64%